Myriad to Acquire Psychiatry-focused PGx Firm Assurex

NEW YORK (GenomeWeb) – Myriad Genetics announced today that it plans to acquire mental health-focused pharmacogenetics firm Assurex Health for $225 million in upfront payments. The deal, which will grant Myriad entry into the neuroscience space, also includes the potential for $185 million in performance-based milestone payments, the company added.


Link to Full Article: Myriad to Acquire Psychiatry-focused PGx Firm Assurex